Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Weiss

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Plos One|March 23, 2012
Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and CNika Strokappe, Agnieszka Szynol, Marlèn Aasa-Chapman, et al.
AIDS Research and Human Retroviruses|August 26, 2011
Llama antibody fragments have good potential for application as HIV type 1 topical microbicidesAndrea Gorlani, Joachim Brouwers, Christopher McConville, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 29, 2025
Surface Localized Coacervation Controlled by Bioactive Nanoarchitectonic Polyelectrolyte MultilayersJean-Yves Runser, Shahaji H More, Robin Weiss, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|September 3, 2010
Natural cases of 2009 pandemic H1N1 Influenza A virus in pet ferretsSabrina L Swenson, Leo G Koster, Melinda Jenkins-Moore, et al.
Journal of Virology|February 28, 2002
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapyJohn Wilkinson, Alethea Cope, Jas Gill, et al.
Retrovirology|May 7, 2017
Professor Mark WainbergMonsef Benkirane, Ben Berkhout, Persephone Borrow, et al.
International Journal of Cancer|November 28, 2002
The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in UgandaRobert Newton, John Ziegler, Dimitra Bourboulia, et al.
International Journal of Cancer|November 28, 2002
Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in UgandaJohn Ziegler, Robert Newton, Dimitra Bourboulia, et al.
Journal of Virology|November 11, 2011
Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomesThushan I de Silva, Marlén Aasa-Chapman, Matthew Cotten, et al.
Plos Pathogens|December 3, 2010
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41Charles Sabin, Davide Corti, Victor Buzon, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Plos One|March 23, 2012
Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and CNika Strokappe, Agnieszka Szynol, Marlèn Aasa-Chapman, et al.
AIDS Research and Human Retroviruses|August 26, 2011
Llama antibody fragments have good potential for application as HIV type 1 topical microbicidesAndrea Gorlani, Joachim Brouwers, Christopher McConville, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 29, 2025
Surface Localized Coacervation Controlled by Bioactive Nanoarchitectonic Polyelectrolyte MultilayersJean-Yves Runser, Shahaji H More, Robin Weiss, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|September 3, 2010
Natural cases of 2009 pandemic H1N1 Influenza A virus in pet ferretsSabrina L Swenson, Leo G Koster, Melinda Jenkins-Moore, et al.
Journal of Virology|February 28, 2002
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapyJohn Wilkinson, Alethea Cope, Jas Gill, et al.
Retrovirology|May 7, 2017
Professor Mark WainbergMonsef Benkirane, Ben Berkhout, Persephone Borrow, et al.
International Journal of Cancer|November 28, 2002
The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in UgandaRobert Newton, John Ziegler, Dimitra Bourboulia, et al.
International Journal of Cancer|November 28, 2002
Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in UgandaJohn Ziegler, Robert Newton, Dimitra Bourboulia, et al.
Journal of Virology|November 11, 2011
Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomesThushan I de Silva, Marlén Aasa-Chapman, Matthew Cotten, et al.
Plos Pathogens|December 3, 2010
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41Charles Sabin, Davide Corti, Victor Buzon, et al.
Pageof 4